Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions

Peter Vogel, Michael S. Donoviel, Robert Read et al. · 2009

Read Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions by Peter Vogel, Michael S. Donoviel, Robert Read et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004112.txt.

Description

Peter Vogel, Michael S. Donoviel, Robert Read, and co-authors partially blocked a lipid enzyme in mice in 2009. S1P is a fat signal that modulates many body processes. Its levels must be tightly regulated inside and outside cells. The enzyme S1PL destroys S1P in the final breakdown step.

Their PLOS ONE article reports incomplete S1PL inhibition reshapes immune function. Partial blocking avoided the early death and organ lesions of full loss. That window matters for drugs that target this enzyme. It suggests immune benefits may come without the worst side effects. It appeared in PLOS ONE, and the full text is free for any reader to check.

Catalog record

CREATORPeter Vogel, Michael S. Donoviel, Robert Read et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004112

Browse the full library · About the Tower of Babel